Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department

SARS-CoV-2 strains healthcare capacity. Better risk stratification, with discharge of patients with a predicted mild disease trajectory can ease this burden. Elevated blood soluble urokinase plasminogen activator receptor (suPAR) has previously been shown associated with risk of intubation in confirmed COVID-19 patients.

Source: The Journal of Emergency Medicine - March 25, 2021 Category: Emergency Medicine Authors: Marius Ahm Stauning, Izzet Altintas, Thomas Kallemose, Jesper Eugen-Olsen, Mette Bendtz Lindstr øm, Line Jee Hartmann Rasmussen, Hejdi Gamst-Jensen, Jan O Nehlin, Ove Andersen, Jens Tingleff Source Type: research